The Iraqi Ministry of Health has launched a $33 million legal actionagainst Merieux in France for having supplied AIDS-contaminated blood in 1986 which infected 123 hemophiliac patients. Merieux became part of Aventis in 1999, following the merger between Rhone-Poulenc and Hoechst (Marketletters passim).
The Iraqi Ministry is claiming some 2 million French francs ($269,000) for each of the patients. Institut Merieux admitted in 1992 that a delivery of unheated and untested Factor VIII had been sent to Iraq in 1986.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze